Guidelines on the selection of patients with lung cancer for surgery

Thorax

Volumn 56, Issue 2, 2001, Pages 89-108

  Armstrong, P ^a   Congleton, J ^a   Fountain, S W ^a   Jagoe, T ^a   McAuley, D F ^a   Macmahon, J ^a   Muers, M F ^a   Page, R D ^a   Plant, P K ^a   Roland, M ^a   Rudd, R M ^a   Walker, W S ^a   Williams, T J ^a   Saunders, M I ^a   Nicholson, A G ^b  

^a ROYAL COLLEGE OF RADIOLOGISTS   (United Kingdom)

^b Royal College of Pathologists   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER SURGERY; CLINICAL PRACTICE; HUMAN; LUNG CANCER; LUNG SURGERY; MEDICAL SOCIETY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; AGED; ARTICLE; BODY WEIGHT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; MIDDLE AGED; MORBIDITY; NEEDLE BIOPSY; NUTRITIONAL STATUS; PATHOLOGY; PATHOPHYSIOLOGY; SMALL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; ELECTROCARDIOGRAPHY; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; NUTRITIONAL STATUS; PATIENT SELECTION; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035129567     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.2.89     Document Type: Review

References (182)

1. BTS Recommendations to respiratory physicians for organising the care of patients with lung cancer
2. Guidelines on the non surgical management of lung cancer
3. National survey of the pattern of care for carcinoma of the lung
4. Variation in survival of patients with lung cancer in Europe 1985-1989
5. Surgery for lung cancer
6. A policy framework for commissioning cancer services
7. Age and the treatment of lung cancer
8. Major pulmonary resection for bronchogenic carcinoma in the elderly
9. Resection for bronchial carcinoma in the elderly
10. Resection rates and postoperative mortality in 7899 patients with lung cancer
11. Pulmonary resections in patients over 70 years of age
12. Bronchogenic cancer in the elderly: Operative risk and long term prognosis
13. Thoracotomy in patients over age seventy years. Ten-year experience
14. The feasibility of thoracotomy for lung cancer in the elderly
15. Modern thirty day operative mortality for surgical resection in lung cancer
16. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer
17. Long-term results in the elderly following pulmonary resection for non-small cell lung carcinoma
18. Long-term results of operation for non-small cell lung cancer in the elderly
19. Hospital mortality and long-term survival after pulmonary resection in the elderly
20. Results of resection for bronchogenic carcinoma in patients over the age of 80
21. Surgical treatment of lung cancer over 80 years of age: Investigation from postoperative complications. Kyobo-Geka
22. Pulmonary resection for lung cancer in octogenarians
23. How risky is lung resection today? Perioperative morbidity and mortality in open thorax surgery
24. Operation for lung cancer in the elderly: What about octogenarians?
25. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma
26. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma
27. Physiologic evaluation of pulmonary function in the candidate for lung resection
28. Use of radionuclide scanning in the preoperative estimation pf pulmonary function after pneumonectomy
29. Pulmonary function evaluation of the lung resection candidate: A prospective study
30. Pre-operative assessment of the high risk patient for lung resection
31. Preoperative risk evaluation for lung cancer resection: Predicted postoperative product as a predictor of surgical mortality
32. Assessment of operative risk in patients undregoing lung resection
33. Preoperative assessment as a predictor for mortality and morbidity after lung resection
34. Exercise testing, 6 min walk and stair climb in the evaluation of patients at high risk of pulmonary resection
35. Postoperative complications after pneumonectomy for treatment of lung cancer, multivariate analysis
36. Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma
37. 1 and complications in lung resection candidates
38. Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma
39. Complications of surgery in the treatment of carcinoma of the lung
40. Diffusing capacity predicts morbidity and mortality after pulmonary resection
41. Optimising selection of patients for major lung resection
42. Prospective evaluation for pneumonectomy using perfusion scanning
43. 133Xe-radiospirometry
44. Prospective evaluation for pneumonectomy using the 99m-technetium quantitative perfusion lung scan
45. Role of lung scanning in assessing the resectability of bronchial carcinoma
46. Prediction of postoperative cardiopulmonary function in patients undergoing pneumonectomy
47. Predicting postoperative pulmonary function in patients undergoing lung resection
48. A method for predicting postoperative lung function and its relationship to postoperative complications in patients with lung cancer
49. Exercise testing in the evaluation of patients at high risk for compliactions from lung resection
50. Evaluation of high-risk lung resection candidates: Pulmonary haemodynamics versus exercise testing
51. Standardised exercise oximetry predicts postpneumonectomy outcome
52. Exercise oximetry versus spirometry in the assessment of risk prior to lung resection
53. Stair climbing as an exercise test to predict the post-operative complications of lung resection
54. Stairclimbing as an indicator of pulmonary function
55. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications
56. Resection of lung cancer is justifed in high-risk patients selected by exercise oxygen consumption
57. Exercise capacity as a predictor of post-thoracotomy morbidity
58. Assessment of exercise oxygen consumption as preoperative criterion for lung resection
59. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation
60. Performance, ventilation and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease
61. Development of a shuttle walking test of disability in patients with chronic airways obstruction
62. Simple exercise testing
63. Reanalysis of the 12-minute walk in patients with chronic obstructive pulmonary disease
64. Cardiac risk fo noncardiac surgery. Influence of coronary disease and type of surgery in 3368 operations
65. ACC/AHA Task Force Special Report. Guidelines for perioperative cardiac evaluation for noncardiac surgery
66. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: An abridged version of the report of the American College of Cardiology/American Heart Association task force on practice guidelines
67. Derivation and prospective validation of a simple index for prediction of cardiac risk of major non-cardiac surgery
68. Is simple clinical assessment adequate for cardiac risk stratification before non-cardiac surgery?
69. Perioperative stroke. Part 1: General surgery, carotid artery disease and carotid endarterectomy
70. Grading of angina pectoris
71. Prognostic factors in nonsmall cell lung cancer: A consensus report
72. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung
73. Assessment of operative risk in patients undergoing lung resection
74. Nutritional state of patients with lung cancer undergoing thoracotomy
75. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma
76. Instant nutritional assessment
77. Impaired wound healing in surgical patients with varying degrees of malnutrition
78. Modern thirty-day operative mortality for surgical resections in lung cancer
79. How reliable is the diagnosis of lung cancer using small biopsy specimens. Report of a UKCCCR Lung Cancer Working Party
80. Revisions in the international system for staging lung cancer
81. Bronchogenie carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling
82. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncologic Group
83. Can computed tomography of the chest stage lung cancer? Yes and no
84. Positron emission tomography in lung cancer
85. The clinical evaluation for detecting metastatic lung cancer: A meta analysis
86. Suspected non-small cell lung cancer: Incidence of occult brain and skeletal metastases and effectiveness of imaging for detection-pilot study
87. Characterisation of adrenal masses using MR imaging with histopathologic correlation
88. Staging of non-small cell lung cancer
89. Aspiration needle biopsy of thoracic lesions
90. Significance of metastatic disease in subaortic lymph nodes
91. Significance of positive mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
92. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer
93. Regional lymph node classification for lung cancer staging
94. Diagnostic anterior mediastinotomy
95. Investigation for mediastinal disease in patients with apparently operable lung cancer
96. Mediastinal lymph node metastases in patients with clinical stage I peripheral non-small cell lung cancer
97. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non small-cell lung cancer A meta-analysis using updated data on individual patients from 52 randomised clinical trials
98. A randomised trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer
99. A randomised trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer
100. Postoperative radiotherapy in non small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials
101. The benefit of adjuvant treatment for resected locally advanced non-small cell lung cancer
102. Safety and efficacy of bronchovascular reconstruction after induction chemotherapy for lung cancer
103. Segmental resection for bronchogenic carcinoma
104. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients
105. Wedge resection for bronchogenic carcinoma in high risk patients
106. Less than lobar resections for bronchogenic carcinoma
107. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma
108. The comparison of limited resection to lobectomy for T1N0 non-small cell lung cancer: LCSG 821
109. Prospective assessment of 30 day operative morbidity for surgical resections in lung cancer
110. Preoperative risk evaluation for lung cancer resection: Predicted postoperative product as a predictor of surgical mortality
111. Lung cancer surgery in the octogenarian
112. Pneumonectomy for bronchogenic carcinoma in the elderly
113. Pulmonary resection for lung cancer in octogenarians
114. Long term survival after resection for bronchogenic carcinoma
115. Four decades of experience with resections for bronchogenic carcinoma at the Massachusetts General Hospital
116. Thirty years of surgery for carcinoma of the bronchus
117. Long term results of operation for non small cell cancer in the elderly
118. Survival and prognosis following resection of primary non small cell bronchogenic carcinoma
119. Bronchogenic carcinoma in patients under age 40
120. Carcinoma of the lung: Results of treatment over ten years
121. Regional lymph node classification for lung cancer staging
122. The long term survival of patients with lung cancer treated surgically after selection by mediastinoscopy
123. Sigificance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
124. Results of resection of T3 non small cell lung cancer invading the mediastinum or main bronchus
125. Are bilobectomies acceptable procedures?
126. Bilobectomy for bronchogenic carcinoma
127. Bronchial sleeve resection with and without pulmonary resection
128. Bronchoplastic and angioplastic operation in bronchial carcinoma: Long-term results of a retrospective analysis from 1973 to 1983
129. TNM staging and long term follow up after sleeve resection for bronchogenic tumours
130. Staging and management of lung cancer: Sleeve resection
131. Morbidity, mortality and survival after bronchoplastic procedures for lung cancer
132. Tracheal sleeve pneumonectomy for bronchogenic carcinoma: Report of 55 cases
133. Carinal resection for bronchogenic carcinoma
134. Tracheal sleeve pneumonectomy for bronchogenic carcinoma
135. Carinal resection for bronchogenic cancer
136. VATS lobectomy: An international survey
137. One hundred video-assisted thoracic surgical simultaneously stapled lobectomies without rib spreading
138. VATS lobectomy: The Edinburgh experience
139. Videothoracoscopic operative staging for lung cancer
140. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: A randomised controlled trial
141. Primary carcinoma of the lung with invasion of the ribs. Pneumonectomy and simultaneous block resection of the chest wall
142. Bronchogenic carcinoma with chest wall invasion: Factors affecting survival following en bloc resection
143. En bloc (non-chest wall) resection for bronchogenic carcinoma with parietal fixation
144. Chest wall invasion in carcinoma of the lung
145. Treatment of bronchogenic carcinoma with chest walt invasion
146. Chest wall involvement by lung cancer: Computed tomographic detection and results of operation
147. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group
148. Surgery in the management of peripheral lung tumors adherent to the pleura
149. The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma
150. Management of tumour adherent to the vertebral column
151. Total vertebrectomy for en bloc resection of lung cancer invading the spine
152. Treatment of the superior sulcus tumour by irradiation followed by resection
153. The importance of defining location and staging of superior pulmonary sulcus tumours
154. Carcinomas in the superior pulmonary sulcus
155. Carcinoma in the superior pulmonary sulcus
156. Treatment of superior sulcus tumours (Pancoast tumour)
157. Influence of surgical resection and brachytherapy in the management of superior sulcus carcinoma
158. Anterior transcervical approach for radical resection of lung tumours invading the thoracic inlet
159. Extended operations for the treatment of lung cancer
160. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus: Ten year follow up
161. Metastatic patterns in small cell lung cancer: Correlation of autopsy findings with clinical parameters
162. What is the best treatment for early operable small cell carcinoma of the bronchus?
163. Survival after resection of small cell carcinoma of the bronchus
164. Surgical resection in the management of small cell carcinoma of the lung
165. Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer
166. The role of surgery in small cell lung cancer (SCLC): An intergroup prospective randomised trial
167. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer
168. Diagnosis, staging and prognostic factors of small cell lung cancer
169. The restaging of responding patients with limited small cell lung cancer
170. Surgical treatment for limited small cell lung cancer
171. Is there a role for salvage operations in limited small cell lung cancer?
172. Neuroendocrine neoplasms of the bronchopulmonary tract